Hepatic Expression of NTN4 and Its Receptors in Patients with Hepatocellular Carcinoma.
Jyothi VennelaBiju PottakkatBala Subramaniyan VairappanSurendra Kumar VermaVictor MukherjeePublished in: Asian Pacific journal of cancer prevention : APJCP (2023)
Systemic and hepatic NTN4 levels were reduced in both PVI and NPVI subjects. The hepatic expression of NTN4 receptors Neogenin and UNC5B were markedly elevated in patients with HCC with PVI compared to NPVI. Future experimental studies might shed the role of NTN4 and its receptors in the development of PVI in HCC.